Lexaria Bioscience To Test Altria-Backed DehydraTECH™ on Animal Seizures

Lexaria Bioscience Corp. isn’t a stranger to Patent Forecast®. In fact, we’ve been watching Lexaria since the acquisition of PoViva Tea to leverage its patented DehydraTECH which improves the delivery of active pharmaceutical ingredients.…

Purissima is Securing Microalgal Cannabinoid Biosynthesis

Biosynthesis of cannabinoids has been a focal point of the cannabis industry the last 5 years. Leaders like Teewinot Life Sciences and CB Therapeutics emerged with scalable platforms for the synthesis of active pharmaceutical ingredients…

Latest Cannabis Patent Infringement Lawsuit – Who Could Be Next?

In what was supposed to be a pivotal case in cannabis, the United Cannabis v. Pure Hemp Collective patent litigation was brought to a less than desired ending when UCANN announced bankruptcy and sitting Judge William J. Martinez closed the…

First True THCV Cultivars Patented by GenCann, LLC

GenCann, LLC, previously highlighted by Patent Forecast® in October 2020, was just granted three patents (its first patents to be granted) on June 29, 2021 for its primarily THCV cultivar cannabis plants named ‘V1’, ‘V2’, and ‘V3’. The…

Big Tobacco’s Interest in Big Cannabis Heats Up With 29 New Patent Filings

Seeing a company apply for multiple patent assets shows a determination to lead in that space. After all, patent investment always leads market activity and is a great indicator for future M&A activity. British American Tobacco’s (BAT)…

Is Cryptocurrency Cannabis’ Banking Solution?

Cryptocurrency has been trending since redditors sent the Gamestop stock soaring to the moon with their targets now set on Dogecoin. Recently, more people have come to trust the digital currency especially with the attention it has…

NC Company Ensures When You Buy Cannabis You See Cannabis Ads.

In 2020, US cannabis sales grew by 46% to reach a total of $17.5 billion, according to Colorado-based cannabis research firmBDSA. Inmar Clearing, Inc. of North Carolina DBA Carolina Services wants to target cannabis promotions to people…

Driving While High? Cannabis Sobriety Testing Heats Up

What’s the future of cannabis innovation? We see things before they happen using our Patent Forecast®. One of those is the development of sobriety tests for what is bound to become a future issue in America. That is, driving while high.…

Patent Forecast Predicts GW Pharmaceuticals Acquisition

Wednesday’s news of GW Pharmaceuticals’ acquisition by Jazz Pharma for $7.2Billion may have taken you by surprise, but we were expecting M&A activity soon. After all, GW Pharmaceuticals has grown to become the largest patent holder in…

GAIACA Takes an Early Lead in the Cannabis Waste Category

Cultivating cannabis comes with compliance requirements, but did you know disposal of cannabis waste also does? Since often the cannabis waste material contains cannabinoids, it must be disposed of in a compliant manner. That's where…

Remnants of GW Pharma and Otsuka Pharmaceuticals Partnership Still Flowing in

Although nixed in 2017, remnants of the GW Pharmaceuticals plc and Otsuka Pharmaceuticals Co. Limited partnership are still publishing to the USPTO database. In December of 2017, GW Pharmaceuticals regained full rights to develop and…

3 Cannabis Cultivar Plant Patents Applied for by GenCann Inventors

This October, three (3) plant patent applications (US Patent Pub. Nos. 20200329599, ‚Äò600, & ‚Äò601) filed by GenCann, LLC inventors were published for three cannabis cultivars, "V1," "V2," and "V3" which contain a higher amount of…

HOLY CRUNCH – Cultivar with a Punch

Biotech Institute of West Lake, CA received another plant patent (PP31874) for a cannabis cultivar named ‚ÄòHOLY CRUNCH', bringing Biotech to a total of 5 issued plant patents in the US. HOLY CRUNCH is characterized as having a maximum…

University of North Texas Helping Officials Detect Cannabinoids in the Breath

Last year, Texas defined hemp as any cannabis plant with less than 0.3% THC and marijuana as any cannabis plant having more than that, but cops complained about the difficulties around making this distinction in the field.  The…

Targeted Therapies Using Cannabinoids

Targeted therapies using cannabinoids could be coming sooner than expected. Published this week was a patent (US Pat. 10,676,781) for functional ligands to THC using in particular synthesized nucleic acids to target THC, known as aptamers.…

Patent Forecast® gives you AI-driven, interactive data that identifies key innovators and first movers.

Includes interactive Patent Radian, real-time USPTO updates, and market insights.

TRY IT FREE FOR 7 DAYS